PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

A Glaviano, ASC Foo, HY Lam, KCH Yap, W Jacot… - Molecular cancer, 2023 - Springer
Abstract The PI3K/AKT/mTOR (PAM) signaling pathway is a highly conserved signal
transduction network in eukaryotic cells that promotes cell survival, cell growth, and cell …

Breast cancer treatments: updates and new challenges

A Burguin, C Diorio, F Durocher - Journal of personalized medicine, 2021 - mdpi.com
Breast cancer (BC) is the most frequent cancer diagnosed in women worldwide. This
heterogeneous disease can be classified into four molecular subtypes (luminal A, luminal B …

[HTML][HTML] Risk factors and preventions of breast cancer

YS Sun, Z Zhao, ZN Yang, F Xu, HJ Lu… - … journal of biological …, 2017 - ncbi.nlm.nih.gov
Breast cancer is the second leading cause of cancer deaths among women. The
development of breast cancer is a multi-step process involving multiple cell types, and its …

Advances in studies of tyrosine kinase inhibitors and their acquired resistance

Q Jiao, L Bi, Y Ren, S Song, Q Wang, Y Wang - Molecular cancer, 2018 - Springer
Protein tyrosine kinase (PTK) is one of the major signaling enzymes in the process of cell
signal transduction, which catalyzes the transfer of ATP-γ-phosphate to the tyrosine residues …

Targeting GSK3 and associated signaling pathways involved in cancer

P Duda, SM Akula, SL Abrams, LS Steelman… - Cells, 2020 - mdpi.com
Glycogen synthase kinase 3 (GSK-3) is a serine/threonine (S/T) protein kinase. Although
GSK-3 originally was identified to have functions in regulation of glycogen synthase, it was …

Signal transduction pathways in breast cancer: the important role of PI3K/Akt/mTOR

MA Ortega, O Fraile-Martínez, Á Asúnsolo… - Journal of …, 2020 - Wiley Online Library
Breast cancer is the cancer with the highest prevalence in women and is the number‐one
cause of cancer mortality worldwide. Cell transduction is a fundamental process in the …

Breast cancer models: Engineering the tumor microenvironment

G Bahcecioglu, G Basara, BW Ellis, X Ren, P Zorlutuna - Acta biomaterialia, 2020 - Elsevier
The mechanisms behind cancer initiation and progression are not clear. Therefore,
development of clinically relevant models to study cancer biology and drug response in …

Genistein as potential therapeutic candidate for menopausal symptoms and other related diseases

P Thangavel, A Puga-Olguín, JF Rodríguez-Landa… - Molecules, 2019 - mdpi.com
Plant-derived compounds have recently attracted greater interest in the field of new
therapeutic agent development. These compounds have been widely screened for their …

Understanding genistein in cancer: The “good” and the “bad” effects: A review

M Russo, GL Russo, M Daglia, PD Kasi, S Ravi… - Food chemistry, 2016 - Elsevier
Nowadays, diet and specific dietary supplements are seen as potential adjuvants to prevent
different chronic diseases, including cancer, or to ameliorate pharmacological therapies …

[HTML][HTML] Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity—Diverse effects on cell growth, metabolism and cancer

JA McCubrey, D Rakus, A Gizak, LS Steelman… - … et Biophysica Acta (BBA …, 2016 - Elsevier
Abstract Glycogen synthase kinase-3 (GSK-3) is a serine/threonine kinase that participates
in an array of critical cellular processes. GSK-3 was first characterized as an enzyme that …